Investegate announcements from Galapagos NV, Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022
Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission
Investegate announcements from Galapagos NV, Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
A cohort study of German patients with and without the disease found no major sex-specific differences for erosion and bone marrow edema but did find differences in ankylosis, fat metaplasia, and sclerosis.
Janus kinase inhibitors have delivered on some, but not all, of the promises that were expected of them upon approval in 2012, a speaker said at EULAR 2022 Congress.“I am trying to bring to you arguments for why particular promises associated with JAK inhibition have been fulfilled and why others have not,” Hendrik Schulze-Koops, MD, of the Ludwig Maximilian University of Munich, said